Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Insulin Market Competition: Payers Watching FDA 'Transition' Policy

Jul 07 2017

• By Cathy Kelly

Anti-recessionary injection (vaccination) by hundred dollar denomination close up on a black background

Related Content

FDA Getting Reg Slashing Directive In Trump Executive Order

Jun 24 2017

Insulin Exclusivity: How Big Will The Fight Be?

Mar 21 2016

FDA Biologic Transition Plan Creates 'Dead Zone' For Applications, Sponsors Fear

May 23 2016

Related Companies

Express Scripts Holding Company

Novo Nordisk A/S

Eli Lilly and Company

Boehringer Ingelheim GmbH

Sanofi

Samsung Bioepis Co., Ltd.

Merck & Co., Inc.

Viatris Inc.

Biocon, Ltd.

Additional Topics

United States Biosimilars Generic Drugs Drug Review Pricing Debate Commercial Metabolic Disorders BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window